honokiol has been researched along with Cancer of Colon in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, SS; Kim, WK; Lee, MA; Lee, SK; Park, HJ | 1 |
| He, BC; Li, Q; Liu, XL; Ma, Y; Mu, L; Sun, WJ; Wu, K | 1 |
| Anant, S; Dandawate, P; Jensen, RA; Kwatra, D; Ponnurangam, S; Ramalingam, S; Subramaniam, D; Umar, S; Weir, SJ | 1 |
| He, BC; Jiang, HT; Liao, YP; Liu, RX; Ma, Y; Ren, WY; Sun, WJ; Wang, H; Wu, K; Zhu, JH | 1 |
| Chen, W; Hua, H; Shen, L; Sheng, Q; Teng, L | 1 |
| Bauer, R; Bernaskova, M; Huefner, A; Kretschmer, N; Schuehly, W; Weis, R | 1 |
| Chen, L; Deng, H; Ding, Z; Gou, L; Lai, S; Li, J; Liu, H; Mao, Y; Nie, C; Wang, Y; Wei, Y; Yan, F; Yuan, Z; Zhao, X; Zhao, Y | 1 |
| Gong, C; Guo, G; Luo, F; Mao, Y; Qian, Z; Wang, X; Wang, Y; Wei, X | 1 |
| Anant, S; He, Z; Mammen, JM; Ponnurangam, S; Ramalingam, S; Subramaniam, D; Umar, S; Zhang, Y | 1 |
9 other study(ies) available for honokiol and Cancer of Colon
| Article | Year |
|---|---|
Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Axin Protein; beta Catenin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Flavonolignans; Humans; Lignans; Lonicera; RNA Interference; RNA, Small Interfering; Wnt Proteins; Wnt Signaling Pathway | 2013 |
Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Bone Morphogenetic Protein 7; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Female; Humans; Lignans; Mice; Mice, Nude; Signal Transduction; Transforming Growth Factor beta1; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2020 |
Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Biphenyl Compounds; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colitis; Colonic Neoplasms; Doublecortin-Like Kinases; Down-Regulation; Hippo Signaling Pathway; Humans; Intracellular Signaling Peptides and Proteins; Lignans; Male; Mice, Inbred ICR; Models, Biological; Neoplastic Stem Cells; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Signal Transduction; Transcription Factors; Tumor Stem Cell Assay; YAP-Signaling Proteins | 2021 |
BMP7 mediates the anticancer effect of honokiol by upregulating p53 in HCT116 cells.
Topics: Apoptosis; Biphenyl Compounds; Bone Morphogenetic Protein 7; Cell Proliferation; Cell Survival; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Lignans; Signal Transduction; Smad Proteins; Tumor Suppressor Protein p53 | 2017 |
Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Blotting, Western; Caspase 3; Cell Line; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; HT29 Cells; Humans; Lignans; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor A | 2013 |
Synthesis of tetrahydrohonokiol derivates and their evaluation for cytotoxic activity against CCRF-CEM leukemia, U251 glioblastoma and HCT-116 colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Survival; Colonic Neoplasms; Drug Screening Assays, Antitumor; Glioblastoma; HCT116 Cells; Humans; Inhibitory Concentration 50; Leukemia; Lignans; Methylation; Microwaves | 2014 |
Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Carcinoma, Lewis Lung; Cell Proliferation; Colonic Neoplasms; Combined Modality Therapy; Female; Genetic Therapy; Humans; In Situ Nick-End Labeling; Lignans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitric Oxide Synthase; Tumor Cells, Cultured | 2009 |
Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biphenyl Compounds; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Drug Delivery Systems; Drug Screening Assays, Antitumor; Drug Stability; Drugs, Chinese Herbal; Humans; Lignans; Lung Neoplasms; Mice; Micelles; Microscopy, Electron, Transmission; Particle Size; Polyesters; Polyethylene Glycols; Solubility; Sonication; X-Ray Diffraction | 2010 |
Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells.
Topics: Animals; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Combined Modality Therapy; Down-Regulation; Drugs, Chinese Herbal; HCT116 Cells; Humans; Immunohistochemistry; Lignans; Male; Mice; Mice, Nude; Neoplastic Stem Cells; Nitric Oxide Synthase; Signal Transduction; Transfection; Xenograft Model Antitumor Assays | 2012 |